Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,100 | 86,900 | 68,500 | 120,500 | 134,700 |
| Marketable Securities | 54,400 | 61,500 | 90,500 | 96,200 | 84,600 |
| Receivables | 111,500 | 102,800 | 95,000 | 94,000 | 89,400 |
| Inventories | 51,300 | 53,900 | 38,300 | 25,300 | 29,100 |
| TOTAL | $341,600 | $322,900 | $314,500 | $372,400 | $375,500 |
| Non-Current Assets | |||||
| PPE Net | 54,700 | 56,800 | 58,300 | 60,000 | 61,700 |
| Investments And Advances | 55,500 | 52,200 | 79,900 | 69,700 | 66,200 |
| Intangibles | 821,800 | 834,000 | 422,800 | 361,100 | 363,300 |
| Other Non-Current Assets | 2,500 | 5,000 | 5,000 | 5,000 | 5,000 |
| TOTAL | $934,500 | $948,000 | $566,000 | $495,800 | $496,200 |
| Total Assets | $1,276,100 | $1,270,900 | $880,500 | $868,200 | $871,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,900 | 19,900 | 21,100 | 13,800 | 16,500 |
| Accrued Expenses | 57,700 | 54,800 | 49,500 | 50,800 | 47,900 |
| TOTAL | $82,800 | $274,900 | $72,300 | $66,100 | $65,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 204,000 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 2,200 | 1,000 | 1,700 | 1,500 | 1,500 |
| Other Non-Current Liabilities | 170,500 | 173,100 | 42,200 | 31,700 | 34,700 |
| TOTAL | $460,600 | $260,700 | $60,100 | $31,900 | $35,000 |
| Total Liabilities | $543,400 | $535,600 | $132,400 | $98,000 | $100,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,092 | 68,416 | N/A | 70,299 | 71,252 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | -85,700 | -86,500 | -73,200 | -69,200 | -68,600 |
| Other shareholders' equity | -14,100 | -5,800 | -9,500 | -8,300 | -9,100 |
| TOTAL | $732,700 | $735,300 | $748,100 | $770,200 | $770,800 |
| Total Liabilities And Equity | $1,276,100 | $1,270,900 | $880,500 | $868,200 | $871,700 |